457 related articles for article (PubMed ID: 24752421)
1. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
[TBL] [Abstract][Full Text] [Related]
2. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
[TBL] [Abstract][Full Text] [Related]
4. Glucuronidation of capsaicin by liver microsomes and expressed UGT enzymes: reaction kinetics, contribution of individual enzymes and marked species differences.
Sun H; Wang H; Liu H; Zhang X; Wu B
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1325-36. PubMed ID: 25219630
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of glucuronidation of vanillin: identification of human UDP-glucuronosyltransferases and species differences.
Yu J; Han JC; Hua LM; Gao YJ
Phytother Res; 2013 Sep; 27(9):1392-7. PubMed ID: 23184728
[TBL] [Abstract][Full Text] [Related]
6. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
Tachibana M; Tanaka M; Masubuchi Y; Horie T
Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
[TBL] [Abstract][Full Text] [Related]
7. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences.
Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L
Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899
[TBL] [Abstract][Full Text] [Related]
8. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
9. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.
Kaku T; Ogura K; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
Biochem Pharmacol; 2004 Jun; 67(11):2093-102. PubMed ID: 15135306
[TBL] [Abstract][Full Text] [Related]
10. Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.
Ogura K; Ishikawa Y; Kaku T; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
Biochem Pharmacol; 2006 Apr; 71(9):1358-69. PubMed ID: 16480962
[TBL] [Abstract][Full Text] [Related]
11. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
Sun H; Zhang T; Wu Z; Wu B
J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
[TBL] [Abstract][Full Text] [Related]
12. Hepatic glucuronidation of tetrabromobisphenol A and tetrachlorobisphenol A: interspecies differences in humans and laboratory animals and responsible UDP-glucuronosyltransferase isoforms in humans.
Hanioka N; Isobe T; Saito K; Nagaoka K; Mori Y; Jinno H; Ohkawara S; Tanaka-Kagawa T
Arch Toxicol; 2024 Mar; 98(3):837-848. PubMed ID: 38182911
[TBL] [Abstract][Full Text] [Related]
13. Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver.
Mano Y; Usui T; Kamimura H
Eur J Clin Pharmacol; 2007 Mar; 63(3):289-96. PubMed ID: 17245571
[TBL] [Abstract][Full Text] [Related]
14. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
[TBL] [Abstract][Full Text] [Related]
15. Highly selective N-glucuronidation of four piperazine-containing drugs by UDP-glucuronosyltransferase 2B10.
Lu D; Dong D; Wu B
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):989-998. PubMed ID: 30049229
[TBL] [Abstract][Full Text] [Related]
16. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
17. Characterization of afloqualone N-glucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s).
Kaji H; Kume T
Drug Metab Dispos; 2005 Jan; 33(1):60-7. PubMed ID: 15475412
[TBL] [Abstract][Full Text] [Related]
18. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
Rowland A; Knights KM; Mackenzie PI; Miners JO
Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes.
Liu H; Wu Z; Ma Z; Wu B
Biopharm Drug Dispos; 2014 Dec; 35(9):513-24. PubMed ID: 25099990
[TBL] [Abstract][Full Text] [Related]
20. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases.
Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A
Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]